EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'
-
Considerations for Flow Cytometry Gating To achieve accurate results, it is important to use an optimal gating strategy when assessing cell samples via flow cytometry -
How to Isolate Cells Directly from Whole Blood - EasySep™ Direct Protocol, EasyEights Magnet How to isolate highly purified immune cells from up to 16 whole blood samples at once with EasySep™ Direct on the EasyEights EasySep™ Magnet and the protocol takes as little as 25 minutes from start to finish -
How to Prepare a Single-Cell Suspension from Primary Tissue Samples (e.g. Mouse Spleen) How to harvest cells from a mouse spleen and prepare a single cell suspension prior to performing cell isolation to enable cell separation by minimizing additional cell loss and improving the labeling of target cells -
“The Power of Cell Therapy” Featuring Dr. Jeffrey Bluestone On this episode of the Immunology Podcast, Dr. Jeffrey Bluestone talks about leveraging the properties of regulatory T cells to create living cell therapies that prevent or slow autoimmune disease progression. -
EasySep™: Powerful Immunomagnetic Isolation of Virtually Any Cell Type EasySep™ is a powerful immuno-cell separation tech that combines the specificity of mAbs with the simplicity of a column-free system to isolate purified cells -
How to Isolate Cells Directly from Whole Blood Using the Easy 50 EasySep™ Magnet: 30-Minute Protocol How to isolate highly purified immune cells directly from whole blood samples of up to 30 mL with and the protocol takes as little as 30 minutes from start to finish -
Comparison of Mouse Immune Cell Isolation Protocols: EasySep™ vs. Column-Based Magnetic Separation A head-to-head, in-lab comparison of two mouse immune cell isolation protocols: the 15-minute EasySep™ cell isolation kit and a traditional column-based cell isolation kit -
Combining CAR T Cells with STING Agonists to Fight Solid Tumors In this webinar, Dr. Uslu describes how IMSA101 enhances CAR T function through STING agonist-induced IL-18 secretion and how these findings lay the foundation for advancing the combinatorial approach into a clinical setting.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts. -
Bhushan Dharmadhikari, PhD Dr. Bhushan Dharmadhikari shares his work studying dendritic cells and their applications in cancer immunology and immunotherapy
